Galectin-1 augments Ras activation and diverts Ras signals to Raf-1 at the expense of phosphoinositide 3-kinase
- PMID: 12149263
- DOI: 10.1074/jbc.M205698200
Galectin-1 augments Ras activation and diverts Ras signals to Raf-1 at the expense of phosphoinositide 3-kinase
Abstract
Ras proteins activate diverse effector molecules. Depending on the cellular context, Ras activation may have different biological consequences: induction of cell proliferation, senescence, survival, or death. Augmentation and selective activation of particular effector molecules may underlie various Ras actions. In fact, Ras effector-loop mutants interacting with distinctive effectors provide evidence for such selectivity. Interactions of active Ras with escort proteins, such as galectin-1, could also direct Ras selectivity. Here we show that in comparison with Ras transfectants, H-Ras/galectin-1 or K-Ras4B/galectin-1 co-transfectants exhibit enhanced and prolonged epidermal growth factor (EGF)-stimulated increases in Ras-GTP, Raf-1 activity, and active extracellular signal-regulated kinase. Galectin-1 antisense RNA inhibited these EGF responses. Conversely, Ras and galectin-1 co-transfection inhibited the EGF-stimulated increase in phosphoinositide 3-kinase (PI3K) activity. Galectin-1 transfection also inhibited Ras(G12V)-induced PI3K but not Raf-1 activity. Galectin-1 co-immunoprecipitated with Ras(G12V) or with Ras(G12V/T35S) that activate Raf-1 but not with Ras(G12V/Y40C) that activates PI3K. Thus, galectin-1 binds active Ras and diverts its signal to Raf-1 at the expense of PI3K. This demonstrates a novel mechanism controlling the duration and selectivity of the Ras signal. Ras gains selectivity when it is associated with galectin-1, mimicking the selectivity of Ras(T35S), which activates Raf-1 but not PI3K.
Similar articles
-
Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity.J Biol Chem. 2004 Aug 13;279(33):34922-30. doi: 10.1074/jbc.M312697200. Epub 2004 Jun 17. J Biol Chem. 2004. PMID: 15205467
-
Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak.Curr Biol. 2000 Mar 9;10(5):281-4. doi: 10.1016/s0960-9822(00)00359-6. Curr Biol. 2000. PMID: 10712905
-
H-Ras/mitogen-activated protein kinase pathway inhibits integrin-mediated adhesion and induces apoptosis in osteoblasts.J Biol Chem. 2002 Jun 14;277(24):21446-52. doi: 10.1074/jbc.M202238200. Epub 2002 Apr 4. J Biol Chem. 2002. PMID: 11934900
-
Spatiotemporal organization of Ras signaling: rasosomes and the galectin switch.Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):471-95. doi: 10.1007/s10571-006-9059-3. Epub 2006 May 12. Cell Mol Neurobiol. 2006. PMID: 16691442 Free PMC article.
-
Defining bone fide effectors of RAS GTPases.Bioessays. 2023 Sep;45(9):e2300088. doi: 10.1002/bies.202300088. Epub 2023 Jul 4. Bioessays. 2023. PMID: 37401638 Review.
Cited by
-
Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib.Oncotarget. 2013 Feb;4(2):316-28. doi: 10.18632/oncotarget.867. Oncotarget. 2013. PMID: 23530112 Free PMC article.
-
Detection of ligand- and solvent-induced shape alterations of cell-growth-regulatory human lectin galectin-1 in solution by small angle neutron and x-ray scattering.Biophys J. 2003 Jul;85(1):511-24. doi: 10.1016/S0006-3495(03)74496-8. Biophys J. 2003. PMID: 12829506 Free PMC article.
-
Non-redundancy within the RAS oncogene family: insights into mutational disparities in cancer.Mol Cells. 2009 Oct 31;28(4):315-20. doi: 10.1007/s10059-009-0143-7. Epub 2009 Sep 30. Mol Cells. 2009. PMID: 19812895 Free PMC article. Review.
-
Prevention of induced colitis in mice by the ras antagonist farnesylthiosalicylic acid.Dig Dis Sci. 2012 Feb;57(2):320-6. doi: 10.1007/s10620-011-1880-y. Epub 2011 Sep 8. Dig Dis Sci. 2012. PMID: 21901261
-
Rapalogs can promote cancer cell stemness in vitro in a Galectin-1 and H-ras-dependent manner.Oncotarget. 2017 Jul 4;8(27):44550-44566. doi: 10.18632/oncotarget.17819. Oncotarget. 2017. PMID: 28562352 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous